Use of contraceptive drugs in cardiac patients
Veray, F.X.
Boletin de la Asociacion Medica de Puerto Rico 75(6): 253-254
1983
ISSN/ISBN: 0004-4849 PMID: 6577869 Document Number: 701533
Document emailed within 1 workday
Related Documents
Abu-Zeitone, A.; Peterson, D.R.; Polonsky, B.; McNitt, S.; Moss, A.J. 2014: Oral contraceptive use and the risk of cardiac events in patients with long QT syndrome Heart Rhythm 11(7): 1170-1175Woods, E.R.; Grace, E.; Havens, K.K.; Merola, J.L.; Emans, S.J. 1992: Contraceptive compliance with a levonorgestrel triphasic and a norethindrone monophasic oral contraceptive in adolescent patients American Journal of Obstetrics and Gynecology 166(3): 901-907
Lederer, J. 1983: Cigarettes, contraceptive drugs and lipidogenesis in the female La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(49): 3413-3416
Rabe, T.; Runnebaum, B. 1987: Parenteral contraceptive drugs: depot progestins Wiener Medizinische Wochenschrift 137(20-21): 474-479
Morotti, M.; Remorgida, V.; Venturini, P.L.; Ferrero, S. 2014: Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura European Journal of Obstetrics Gynecology and Reproductive Biology 179: 63-68
Bansal, A. 2009: Drugs for cardiac diseases Indian pediatrics 46(8): 737-8; author reply 738-9
Pack, A.M. 2017: Contraceptive Methods, Seizures, and Antiepileptic Drugs: More Questions Than Answers Epilepsy currents 17(1): 25-28
Gasnault, J.P. 1971: Ovariostatic effect of psychotropic drugs. Initiation to a new contraceptive method La Presse Medicale 79(47): 2128
Wong, I.C. 1997: New antiepileptic drugs. Study suggests that under a quarter of patients will still be taking the new drugs after six years Bmj 314(7080): 603-604
Chong, S.A.; Mythily; Mahendran, R. 2001: Cardiac effects of psychotropic drugs Annals of the Academy of Medicine Singapore 30(6): 625-631
Ball, A.P.; McKee, P.A. 1977: Fibrin formation and dissolution in women receiving oral contraceptive drugs Journal of Laboratory and Clinical Medicine 89(4): 751-762
Lechat, P. 1997: Beta-blockers and new drugs for cardiac failure La Revue du Praticien 47(19): 2131-2134
Piuhola, J.; Tenhunen, O.; Kerkelä, R. 2015: Adverse cardiac effects associated with anticancer drugs Duodecim; Laaketieteellinen Aikakauskirja 131(5): 441-447
Bolooki, H.; Golkar, R.; Vargas, A. 1973: An on-line set-up for continuous monitoring of cardiac muscle performance in postoperative cardiac patients Journal of Cardiovascular Surgery Spec No: 654-660
Hamid, M.; Khan, M.U.; Bashour, A.C. 2006: Diagnostic value of chest X-ray and echocardiography for cardiac tamponade in post cardiac surgery patients JPMA. Journal of the Pakistan Medical Association 56(3): 104-107
Shimada, R.; Araki, H.; Orita, Y.; Nakagaki, O.; Nakamura, M. 1983: Cardiac effects of aprindine in patients with or without cardiac dysfunction: echocardiographic and clinical evaluation Clinical Therapeutics 5(4): 348-356
Featherston, R.G. 1988: Care of sudden cardiac death survivors: the aberrant cardiac patients Heart and Lung: the Journal of Critical Care 17(3): 242-246
Suri, V.; Aggarwal, N.; Kaur, R.; Chaudhary, N.; Ray, P.; Grover, A. 2008: Safety of intrauterine contraceptive device (copper T 200 B) in women with cardiac disease Contraception 78(4): 315-318
Mills, T.M.; Lin, T.J.; Hernandez-Ayup, S.; Greenblatt, R.B.; Ellegood, J.O.; Mahesh, V.B. 1974: The metabolic clearance rate and urinary excretion of oral contraceptive drugs. II. Mestranol American Journal of Obstetrics and Gynecology 120(6): 773-778
Benmimoun, E.G.; Adamec, R.; Rutishauser, W. 1982: Spontaneous cardiac rhythm in patients wearing cardiac stimulators Archives des Maladies du Coeur et des Vaisseaux 75(12): 1381-1387